Seo YH - Search Results

1

Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics.

Sharma C, Seo YH. Sharma C, et al. Among authors: seo yh. Molecules. 2018 Oct 24;23(11):2757. doi: 10.3390/molecules23112757. Molecules. 2018. PMID: 30356024 Free PMC article. Review.

2

Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC).

Jeong CH, Park HB, Jang WJ, Jung SH, Seo YH. Jeong CH, et al. Among authors: seo yh. Bioorg Med Chem Lett. 2014 Jan 1;24(1):224-7. doi: 10.1016/j.bmcl.2013.11.034. Epub 2013 Nov 22. Bioorg Med Chem Lett. 2014. PMID: 24345447

3

Discovery of 2',4'-dimethoxychalcone as a Hsp90 inhibitor and its effect on iressa-resistant non-small cell lung cancer (NSCLC).

Seo YH. Seo YH. Arch Pharm Res. 2015 Oct;38(10):1783-8. doi: 10.1007/s12272-015-0595-6. Epub 2015 Apr 9. Arch Pharm Res. 2015. PMID: 25855012

4

Organelle-specific Hsp90 inhibitors.

Seo YH. Seo YH. Arch Pharm Res. 2015 Sep;38(9):1582-90. doi: 10.1007/s12272-015-0636-1. Epub 2015 Jul 22. Arch Pharm Res. 2015. PMID: 26195286 Review.

5

Chalcone-templated Hsp90 inhibitors and their effects on gefitinib resistance in non-small cell lung cancer (NSCLC).

Jeong JH, Oh YJ, Kwon TK, Seo YH. Jeong JH, et al. Among authors: seo yh. Arch Pharm Res. 2017 Jan;40(1):96-105. doi: 10.1007/s12272-016-0848-z. Epub 2016 Oct 21. Arch Pharm Res. 2017. PMID: 27770383

6

Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors.

Park SY, Oh YJ, Lho Y, Jeong JH, Liu KH, Song J, Kim SH, Ha E, Seo YH. Park SY, et al. Among authors: seo yh. Eur J Med Chem. 2018 Jan 1;143:390-401. doi: 10.1016/j.ejmech.2017.11.054. Epub 2017 Nov 21. Eur J Med Chem. 2018. PMID: 29202402

7

The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.

Oh YJ, Park SY, Seo YH. Oh YJ, et al. Among authors: seo yh. Oncol Rep. 2018 Apr;39(4):1775-1782. doi: 10.3892/or.2018.6250. Epub 2018 Feb 7. Oncol Rep. 2018. PMID: 29436674

8

Evaluation of the Inhibitory Effects of (E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one (DiNap), a Natural Product Analog, on the Replication of Type 2 PRRSV In Vitro and In Vivo.

Khatun A, Park SY, Shabir N, Nazki S, Kang AR, Jeong CG, Seo BJ, Yang MS, Kim B, Seo YH, Kim WI. Khatun A, et al. Among authors: seo bj, seo yh. Molecules. 2019 Mar 3;24(5):887. doi: 10.3390/molecules24050887. Molecules. 2019. PMID: 30832429 Free PMC article.

9

Hair Metabolomics in Animal Studies and Clinical Settings.

Jang WJ, Choi JY, Park B, Seo JH, Seo YH, Lee S, Jeong CH, Lee S. Jang WJ, et al. Among authors: seo yh, seo jh. Molecules. 2019 Jun 12;24(12):2195. doi: 10.3390/molecules24122195. Molecules. 2019. PMID: 31212725 Free PMC article. Review.

10

Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-β probes.

Choi MA, Park SY, Chae HY, Song Y, Sharma C, Seo YH. Choi MA, et al. Among authors: seo yh. Sci Rep. 2019 Sep 12;9(1):13187. doi: 10.1038/s41598-019-49784-9. Sci Rep. 2019. PMID: 31515509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page